Finance

Lists
Why is 002082 down 4,72%?
Dive Deeper
002082:SHE
Wanbangde Pharmaceuticl Hldng Grp Co Ltd
11,51 CN¥
-4,72%
(-0,57) 1D
16 қаз., 15:04:51 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002082...
Open
12,23 CN¥
High
12,50 CN¥
Low
11,50 CN¥
Mkt. cap
7,93 млрд
Avg. vol.
14,37 млн
Volume
11,77 млн
52-wk high
36,24 CN¥
52-wk low
8,53 CN¥
EPS
-0,19 CN¥
Shares outstanding
611,69 млн
No. of employees
1 мың
Open
12,23 CN¥
High
12,50 CN¥
Low
11,50 CN¥
Mkt. cap
7,93 млрд
Avg. vol.
14,37 млн
Volume
11,77 млн
52-wk high
36,24 CN¥
52-wk low
8,53 CN¥
EPS
-0,19 CN¥
Shares outstanding
611,69 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Wanbangde Pharmaceuticl Hldng Grp Co Ltd
CEO-
Employees1,35 мың
Founded1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
439,15 млн
99,62 млн
374,21 млн
214,60 млн
Cost of goods sold
296,93 млн
48,06 млн
161,35 млн
166,88 млн
Cost of revenue
296,93 млн
48,06 млн
161,35 млн
166,88 млн
Research and development expenses
18,12 млн
9,90 млн
11,47 млн
13,48 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
112,01 млн
91,52 млн
80,55 млн
63,97 млн
Operating expense
145,02 млн
166,87 млн
69,10 млн
102,28 млн
Total operating expenses
441,96 млн
214,93 млн
230,45 млн
269,16 млн
Operating income
-2,80 млн
-115,31 млн
143,76 млн
-54,56 млн
Other non operating income
2,27 млн
-1,48 млн
-874,44 м.
-7,73 млн
EBT including unusual items
-9,16 млн
-159,75 млн
129,35 млн
-59,70 млн
EBT excluding unusual items
-11,11 млн
-117,95 млн
132,21 млн
-64,00 млн
Income tax expense
-1,66 млн
13,43 млн
28,69 млн
-16,15 млн
Effective tax rate
18,11%
-8,41%
22,18%
27,04%
Other operating expenses
4,87 млн
2,30 млн
3,07 млн
5,42 млн
Net income
-9,00 млн
-171,70 млн
102,95 млн
-39,67 млн
Net profit margin
-2,05%
-172,36%
27,51%
-18,49%
Earnings per share
-
-
-
-
Interest and investment income
-
11,79 млн
-
7,88 млн
Interest expense
-9,61 млн
-14,74 млн
-10,68 млн
-8,46 млн
Net interest expenses
-9,61 млн
-2,96 млн
-10,68 млн
-578,77 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
21,11 млн
-90,04 млн
169,04 млн
-23,06 млн
Gain or loss from assets sale
297,90 м.
-600,48 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары